• Biochemical Roles of CARMIL's Membrane-Binding Domain in Act

  2026-07-31

  This study uncovers how the membrane-binding (MB) domain of CARMIL orchestrates actin regulation by targeting and releasing capping protein (CP) at membranes, thus facilitating Arp2/3-mediated actin assembly. The findings clarify unresolved mechanisms of CP activation and release, with implications for cytoskeletal research and recombinant protein workflows.

• Hematoxylin and Eosin Staining Kit: Precision in Tissue Morp

  2026-07-31

  The Hematoxylin and Eosin Staining Kit from APExBIO streamlines robust tissue morphology visualization across paraffin and frozen sections, enabling high-contrast, reproducible nuclear and cytoplasmic staining. Its ready-to-use formulation and workflow adaptability empower advanced histopathological analysis and troubleshooting in research settings.

• Practical Guide: Anti-HMGB1 Rabbit Monoclonal Antibody (MA30

  2026-07-30

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) offers specific detection of HMGB1 protein in human, mouse, and rat samples for research workflows, including Western blot, immunohistochemistry, and flow cytometry. This reagent addresses the need for reliable HMGB1 detection in chromatin studies but should not be used for diagnostic or therapeutic purposes.

• Cy3 Goat Anti-Human IgG (H+L) Antibody: Precision in Multipl

  2026-07-30

  The Cy3 Goat Anti-Human IgG (H+L) Antibody empowers researchers with unrivaled sensitivity and workflow versatility across immunofluorescence, IHC, flow cytometry, and ELISA. Its Cy3 conjugation ensures robust, reproducible detection of human IgG, even in challenging multiplexed or low-abundance systems.

• Gene Expression Profiling Predicts PARP Inhibitor Response i

  2026-07-29

  Borchert et al. (2019) demonstrate that defects in homologous recombination repair (HRR), described as BRCAness, are frequent in malignant pleural mesothelioma (MPM) and can predict susceptibility to PARP inhibitor therapy. Their gene expression profiling approach identifies patient subgroups potentially responsive to olaparib, with implications for stratified treatment strategies and future combination protocols.

• Eltanexor (KPT-8602): Shaping Cancer Research via Nuclear Ex

  2026-07-29

  Eltanexor (KPT-8602) is redefining the landscape of cancer therapeutics by targeting XPO1-mediated nuclear export. This thought-leadership article blends mechanistic insight with practical guidance for translational researchers, integrating the latest evidence on Eltanexor's impact on signaling pathways, experimental optimization, and its emerging role in chemoprevention. With a focus on actionable strategy and translational opportunity, we examine how APExBIO’s Eltanexor empowers the field beyond conventional product coverage.

• Bafilomycin C1 in Phenotypic Drug Discovery: Beyond Autophag

  2026-07-28

  Explore how Bafilomycin C1, a potent vacuolar H+-ATPases inhibitor, is revolutionizing phenotypic drug discovery through advanced assay design and high-content screening. Discover unique insights into its mechanistic role in cellular signaling and practical guidance for optimizing experiments.

• Bivalent mRNA Vaccine RQ3025: Broad Protection Against SARS-

  2026-07-28

  The referenced study introduces RQ3025, a bivalent mRNA vaccine designed to induce broad-spectrum immunity against diverse SARS-CoV-2 variants in animal models. This preclinical work highlights the vaccine’s capacity to elicit high-titer neutralizing antibodies and a Th1-skewed cellular response, offering a promising strategy for addressing ongoing viral evolution.

• TPPU and the sEH–Nrf2 Axis: Unlocking Precision in Bone & In

  2026-07-27

  Explore how TPPU, a potent soluble epoxide hydrolase inhibitor, is redefining experimental approaches to bone and inflammation research by enabling precise modulation of fatty acid epoxide signaling. Discover novel insights into the sEH–Nrf2 pathway and practical assay strategies that set this article apart.

• Ivermectin: Mechanistic Precision and Emerging Roles in Para

  2026-07-27

  Explore the advanced mechanisms and research-grade applications of Ivermectin, a broad-spectrum anti-parasitic, with in-depth analysis of its utility in parasitology drug development. This article uniquely bridges mechanistic insight and protocol optimization for translational research.

• Marein Restores Chemosensitivity to Mitoxantrone via ABCG2 I

  2026-07-26

  This study demonstrates that marein, a flavonoid from Coreopsis tinctoria, acts as a competitive inhibitor of the ABCG2 transporter. By blocking ABCG2-mediated drug efflux, marein restores chemosensitivity to anticancer agents such as mitoxantrone, highlighting a promising strategy for overcoming multidrug resistance in cancer research.

• Nilotinib (AMN-107): Data-Driven Reliability in CML Research

  2026-07-25

  This article explores real-world laboratory scenarios where Nilotinib (AMN-107, SKU A8232) from APExBIO addresses common challenges in kinase inhibitor experiments. Through evidence-backed Q&A, we demonstrate how A8232 enhances reproducibility and assay sensitivity in chronic myeloid leukemia and kinase-driven tumor research.

• Fluorescein TSA Fluorescence System Kit: Transforming Endoth

  2026-07-24

  Explore how the Fluorescein TSA Fluorescence System Kit enables ultrasensitive detection of low-abundance biomolecules, with scientific depth on endothelial-centric mechanisms and practical insights for advanced IHC, ICC, and ISH workflows.

• METTL17 Modulates Ferroptosis and Tumorigenesis in Colorecta

  2026-07-24

  This study uncovers METTL17 as a mitochondrial regulator of ferroptosis resistance and tumorigenesis in colorectal cancer, primarily by modulating mitochondrial RNA methylation and translation. The findings reveal a new therapeutic axis for overcoming ferroptosis resistance in CRC, with implications for targeted combination treatments.

• TRPV1+ Nerve Stimulation Modulates Systemic Inflammation via

  2026-07-23

  Song et al. (2025) uncover that targeted stimulation of TRPV1+ peripheral somatosensory nerves at the nape initiates a somato-autonomic reflex, rapidly suppressing systemic inflammation. This mechanistic insight clarifies neuro-immune crosstalk and suggests novel, non-pharmacological approaches to immune modulation.

445 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page